世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000031858

医薬品製造受託市場レポート2022-2032

Visiongain

Pharmaceutical Contract Manufacturing Market Report 2022-2032

発刊日 2022/04/13

言語英語

体裁PDF/441ページ

ライセンス/価格441ページ

0000031858

Single - 1 Year License
(Team License - Up to 6 Users) - 1 Year License
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数5人)をご検討ください。
※詳しくはお問い合わせください。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

サービス別予測(医薬品製造サービス(医薬品API製造サービス、医薬品FDF製造サービス)、医薬品開発サービス、生物製剤受託製造サービス(生物製剤API製造サービス、生物製剤FDF製造サービス))、エンドユーザー別(大手製薬会社、小規模&中規模製薬会社、一般製薬会社、その他)および 地域および主要国市場別分析と主要企業の分析、およびCOVID-19回復シナリオ

CDMOによる先端製造技術への投資

過去数十年の間に、CDMOは、医薬品を本格的に製造するための専門知識と設備を着実に確立してきました。それらは、可能な限り低い運用コストで医薬品を製造するためのさまざまな方法を取り入れています。バッチ処理方式だけでなく、連続製造方式にも投資する受託製造事業者が増えています。先進技術の実用化によって、大手企業は技術開発、加工、生産サービスを追求している企業にCDMOサービスを提供することを計画しています。

また、成長を促進するために、CDMO業界は、高い稼働率に対応して、投資計画に取り組み、メーカーとリスクを共有するため新技術に投資しています。高い利用率からもわかるように、人員の採用も増えています。極めて強力な医薬品有効成分(HPAPI)の製造には、複雑な製造プロセス、高度な合成と配合の専門知識、と特殊な保護具、製造現場、生産プロセス、および管理システムが必要です。CDMOによるこのような戦略的拡張、投資、および買収は、CDMOが提供するサービスを増やし、顧客ベースを拡大すると同時に、重要なクロスセリングの機会を提供するのに役立ちました。

レポート詳細

目次

1 Report Overview
1.1 Introduction to Global Pharmaceutical Contract Manufacturing Market
1.2 Global Pharmaceutical Contract Manufacturing Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Qualitative Analysis of the Global Pharmaceutical Contract Manufacturing Market
3.1 Market Dynamics
3.1.1 Drivers
3.1.1.1 Patent expiry and increasing demand for generic drugs
3.1.1.2 Increasing investments in pharmaceutical R&D
3.1.1.3 Investments in advanced manufacturing technologies by CDMOs
3.1.2 Restraints
3.1.2.1 Introduction of serialization
3.1.3 OPPORTUNITIES
3.1.3.1 Increasing demand for biological therapies
3.1.3.2 Growth in the nuclear medicine sector
3.1.3.3 Growing demand for cell and gene therapies
3.2 SWOT Analysis
3.3 PEST Analysis
3.3.1 Political
3.3.2 Economic
3.3.3 Sociocultural
3.3.4 Technological
3.4 Porter’s Five Forces Analysis
3.4.1 Moderate Bargaining Power of Supplier
3.4.2 High Bargaining Power of Buyer
3.4.3 Low Threat of New Entrants
3.4.4 Low Threat of Substitutes
3.4.5 High Intensity of Competitive Rivalry
3.5 COVID-19 Impact Analysis
3.5.1 V-Shaped Recovery
3.5.2 U-Shaped Recovery
3.5.3 L-Shaped Recovery
3.5.4 W-Shaped Recovery

4 Global Pharmaceutical Contract Manufacturing Market, by Services, 2022-2032
4.1 Global Pharmaceutical Contract Manufacturing Market Forecast by Services, 2022-2032
4.2 PHARMACEUTICAL MANUFACTURING SERVICES
4.2.1 Global Pharmaceutical Contract Manufacturing Market for Pharmaceutical Manufacturing Services by Region: Market Forecast, 2022-2032
4.2.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services: Recovery Scenarios (V, U, W, L)
4.2.3 PHARMACEUTICAL API MANUFACTURING SERVICES
4.2.3.1 Need to cut costs and ensure focus on core areas leads companies to outsource API manufacturing
4.2.3.2 Global Pharmaceutical Contract Manufacturing Market for Pharmaceutical API Manufacturing Services by Region: Market Forecast, 2022-2032
4.2.3.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services: Recovery Scenarios (V, U, W, L)
4.2.4 PHARMACEUTICAL FDF MANUFACTURING SERVICES
4.2.4.1 Global Pharmaceutical Contract Manufacturing Market for Pharmaceutical FDF Manufacturing Services by Region: Market Forecast, 2022-2032
4.2.4.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services: Recovery Scenarios (V, U, W, L)
4.2.4.3 Parenteral/Injectable manufacturing services
4.2.4.3.1 Need for high levels of expertise and growing drug development activities are driving the demand for contract manufacturing
4.2.4.3.2 Global Pharmaceutical Contract Manufacturing Market for Parenteral/injectable manufacturing services: Market Forecast, 2022-2032
4.2.4.4 Tablet manufacturing services
4.2.4.4.1 Shifting manufacturing requirements and the need to streamline production processes are driving market growth
4.2.4.4.2 Global Pharmaceutical Contract Manufacturing Market for Tablet manufacturing services: Market Forecast, 2022-2032
4.2.4.5 Capsule manufacturing services
4.2.4.5.1 Growth in demand for capsule formulations has ensured growth opportunities for service providers
4.2.4.5.2 Global Pharmaceutical Contract Manufacturing Market for Capsule manufacturing services: Market Forecast, 2022-2032
4.2.4.6 Oral liquid manufacturing services
4.2.4.6.1 Complexities involved in oral liquid manufacturing have prompted companies to opt for outsourcing
4.2.4.6.2 Global Pharmaceutical Contract Manufacturing Market for Oral liquid manufacturing services: Market Forecast, 2022-2032
4.2.4.7 Semi-solid manufacturing services
4.2.4.7.1 Demand for specific manufacturing facilities to boost the outsourcing of semi -solids
4.2.4.7.2 Global Pharmaceutical Contract Manufacturing Market for Semi-solid manufacturing services: Market Forecast, 2022-2032
4.2.4.8 Other Formulation manufacturing services
4.2.4.8.1 Demand for specific manufacturing facilities to boost the outsourcing of semi -solids
4.2.4.8.2 Global Pharmaceutical Contract Manufacturing Market for Other Formulation manufacturing services: Market Forecast, 2022-2032
4.3 Drug Development Services
4.3.1 Drug Substance Complexity And High Costs Have Supported The Outsourcing Of Drug Development
4.3.2 Global Pharmaceutical Contract Manufacturing Market for Drug Development Services: Market Forecast, 2022-2032
4.3.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Drug Development Services: Recovery Scenarios (V, U, W, L)
4.4 Biologics Contract Manufacturing Services
4.4.1 Global Pharmaceutical Contract Manufacturing Market for Biologics contract manufacturing services: Market Forecast, 2022-2032
4.4.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services: Recovery Scenarios (V, U, W, L)
4.4.1 Biologics API Manufacturing Services
4.4.1.1 This market is still in the nascent phase
4.4.1.2 Global Pharmaceutical Contract Manufacturing Market for Biologics API Manufacturing Services by Region: Market Forecast, 2022-2032
4.4.1.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services: Recovery Scenarios (V, U, W, L)
4.4.2 Biologics FDF Manufacture Service
4.4.2.1 Increasing R&D costs and process complexity have prompted the shift toward contract manufacturing
4.4.2.2 Global Pharmaceutical Contract Manufacturing Market for Biologics FDF Manufacture Service by Region: Market Forecast, 2022-2032
4.4.2.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service: Recovery Scenarios (V, U, W, L)

5 Global Pharmaceutical Contract Manufacturing Market, by End User, 2022-2032
5.1 Global Pharmaceutical Contract Manufacturing Market Forecast by End User, 2022-2032
5.2 Big Pharmaceutical Companies
5.2.1 Global Pharmaceutical Contract Manufacturing Market for Big Pharmaceutical Companies by Region: Market Forecast, 2022-2032
5.2.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Big pharmaceutical companies: Recovery Scenarios (V, U, W, L)
5.3 Small & Medium-Sized Pharmaceutical Companies
5.3.1 Growing Development Of Biologic Drugs And High Pricing Pressure To Boost Market Growth
5.3.2 Global Pharmaceutical Contract Manufacturing Market for Small & Medium-Sized Pharmaceutical Companies by Region: Market Forecast, 2022-2032
5.3.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Small & Medium-Sized Pharmaceutical Companies: Recovery Scenarios (V, U, W, L)
5.4 Generic Pharmaceutical Companies
5.4.1 Growing Demand For Generics To Support Market Growth
5.4.2 Global Pharmaceutical Contract Manufacturing Market for Generic Pharmaceutical Companies by Region: Market Forecast, 2022-2032
5.4.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Generic Pharmaceutical Companies: Recovery Scenarios (V, U, W, L)
5.5 Other End Users
5.5.1 Global Pharmaceutical Contract Manufacturing Market for Other End Users by Region: Market Forecast, 2022-2032
5.5.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Other End Users: Recovery Scenarios (V, U, W, L)

6 North America Pharmaceutical Contract Manufacturing Market, 2022-2032
6.1.1 COVID-19 Impact on North America Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
6.2 North America Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
6.2.1 North America Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
6.2.2 North America Biologics Manufacturing Market Forecast, by Type, 2022-2032
6.3 North America Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
6.4 North America Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
6.5 US
6.5.1 The US dominates the North American Pharmaceutical Contract manufacturing market
6.5.2 Increasing funding from Federal Government
6.5.3 U.S. Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
6.5.4 US Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
6.5.5 US Biologics Manufacturing Market Forecast, by Type, 2022-2032
6.5.6 US Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
6.5.7 COVID-19 Impact on US Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
6.6 Canada
6.6.1 Rising incidence of chronic lifestyle diseases is expected to boost the market growth
6.6.2 Government initiatives to promote pharmaceutical contract manufacturing in various indications to drive market growth in Canada
6.6.3 Canada Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
6.6.4 Canada Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
6.6.5 Canada Biologics Manufacturing Market Forecast, by Type, 2022-2032
6.6.6 Canada Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
6.6.7 COVID-19 Impact on Canada Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)

7 Europe Pharmaceutical Contract Manufacturing Market, 2022-2032
7.1.1 COVID-19 Impact on Europe Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.2 Europe Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.2.1 Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.2.2 Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.3 Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.4 Europe Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
7.5 Germany
7.5.1 High healthcare expenditure by the country
7.5.2 Increased pharmaceutical production to support market demand
7.5.3 Germany Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.5.4 Germany Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.5.5 Germany Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.5.6 Germany Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.5.7 COVID-19 Impact on Germany Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.6 UK
7.6.1 Growth In The Generics Market And The Rising Cost Of Manufacturing Parenteral Formulations Are Driving Market Growth
7.6.2 Increasing R&D research will boost the market
7.6.3 UK Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.6.4 UK Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.6.5 UK Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.6.6 UK Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.6.7 COVID-19 Impact on UK Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.7 Switzerland
7.7.1 Large volume of pharmaceutical production and growing scope for generics to provide growth opportunities
7.7.2 Switzerland boasts a strong research oriented pharma industry, a key factor supporting market growth.
7.7.3 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.7.4 Switzerland Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.7.5 Switzerland Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.7.6 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.7.7 COVID-19 Impact on Switzerland Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.8 France
7.8.1 Presence of leading pharmaceutical companies to support market growth in France
7.8.2 Availability of reimbursement
7.8.3 France Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.8.4 France Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.8.5 France Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.8.6 France Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.8.7 COVID-19 Impact on France Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.9 Italy
7.9.1 Increasing focus on clinical research and the growing popularity of branded drugs are driving the demand for contract development and manufacturing
7.9.2 Economic slowdown of Italian healthcare industry
7.9.3 Italy Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.9.4 Italy Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.9.5 Italy Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.9.6 Italy Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.9.7 COVID-19 Impact on Italy Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.10 Spain
7.10.1 Increase in biologics production to support market growth
7.10.2 Advancement in the production and research of innovative drugs
7.10.3 Spain Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.10.4 Spain Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.10.5 Spain Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.10.6 Spain Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.10.7 COVID-19 Impact on Spain Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.11 Rest of Europe
7.11.1 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.11.2 Rest of Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.11.3 Rest of Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.11.4 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.11.5 COVID-19 Impact on Rest of Europe Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)

8 Asia-Pacific Pharmaceutical Contract Manufacturing Market, 2022-2032
8.1.1 COVID-19 Impact on Asia-Pacific Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.2 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.2.1 Asia-Pacific Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.2.2 Asia-Pacific Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.3 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.4 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
8.5 Japan
8.5.1 Growing generics demand to drive the demand for contract manufacturing of drugs
8.5.2 Government initiatives to increase the use of generic drugs
8.5.3 Japan Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.5.4 Japan Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.5.5 Japan Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.5.6 Japan Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.5.7 COVID-19 Impact on Japan Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.6 China
8.6.1 Favourable government regulations are fuelling market growth in China
8.6.2 Strong focus of key market players to expand their business In China
8.6.3 China Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.6.4 China Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.6.5 China Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.6.6 China Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.6.7 COVID-19 Impact on China Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.7 India
8.7.1 Low manufacturing costs is attracting outsourcing
8.7.2 Presence of skilled workforce
8.7.3 India Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.7.4 India Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.7.5 India Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.7.6 India Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.7.7 COVID-19 Impact on India Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.8 South Korea
8.8.1 Government investments are a key contributor to market growth in South Korea
8.8.2 Increase in initiative of government research funding
8.8.3 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.8.4 South Korea Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.8.5 South Korea Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.8.6 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.8.7 COVID-19 Impact on South Korea Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.9 Rest of APAC
8.9.1 Singapore and Malaysia are major markets in Rest of APAC
8.9.2 Taiwan and Malaysia are some of the emerging countries
8.9.3 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.9.4 Rest of APAC Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.9.5 Rest of APAC Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.9.6 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.9.7 COVID-19 Impact on Rest of APAC Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)

9 Latin America, Middle East & Africa (LAMEA) Pharmaceutical Contract Manufacturing Market, 2022-2032
9.1.1 COVID-19 Impact on LAMEA Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
9.2 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.2.1 LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.2.2 LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.3 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.4 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
9.5 Brazil
9.5.1 Increasing focus of BNCs on the pharmaceutical and healthcare sectors
9.5.2 Production-development partnerships have been implemented
9.5.3 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.5.4 Brazil Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.5.5 Brazil Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.5.6 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.5.7 COVID-19 Impact on Brazil Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
9.6 Mexico
9.6.1 One of the largest exporters of pharmaceutical products in Latin America
9.6.2 Increased focus among key players to expand their business in Mexico
9.6.3 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.6.4 Mexico Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.6.5 Mexico Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.6.6 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.6.7 Mexico
9.6.8 COVID-19 Impact on Mexico Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
9.7 Saudi Arabia
9.7.1 Largest pharmaceutical market in the Middle East
9.7.2 High-profile agreements and collaborations in the country
9.7.3 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.7.4 Saudi Arabia Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.7.5 Saudi Arabia Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.7.6 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.7.7 COVID-19 Impact on Saudi Arabia Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
9.8 Rest of LAMEA
9.8.1 Government initiatives to tackle the growing burden of pharmaceutical costs
9.8.2 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.8.3 Rest of LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.8.4 Rest of LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.8.5 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.8.6 COVID-19 Impact on Rest of LAMEA Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)

10 Company Profiles
10.1 Market Share Analysis
10.2 LONZA GROUP
10.2.1 Company overview
10.2.2 Company Snapshot
10.2.3 Service Portfolio
10.2.4 Financial Analysis
10.2.4.1 Net Revenue, 2016-2020
10.2.4.2 Segmental Revenue Shares, 2020
10.2.4.3 Regional Revenue Shares, 2020
10.2.5 Recent Developments, 2017-2020
10.3 THERMO FISHER SCIENTIFIC INC.
10.3.1 Company overview
10.3.2 Company Snapshot
10.3.3 Service Portfolio
10.3.4 Financial Analysis Net Revenue, 2016-2020
10.3.4.1 Segmental Revenue Shares, 2020
10.3.4.2 Regional Revenue Shares, 2020
10.3.5 Recent Developments, 2018-2020
10.4 CATALENT
10.4.1 Company Overview
10.4.2 Company Snapshot
10.4.3 Service Portfolio
10.4.4 Financial Analysis
10.4.4.1 Net Revenue, 2016-2020
10.4.4.2 Segmental Revenue Shares, 2021
10.4.4.3 Regional Revenue Shares, 2021
10.4.5 Recent Developments, 2018-2020
10.5 RECIPHARM AB
10.5.1 Company Overview
10.5.2 Company Snapshot
10.5.3 Service Portfolio
10.5.4 Financial Analysis
10.5.4.1 Net Revenue, 2016-2020
10.5.4.2 Segmental Revenue Shares, 2020
10.5.5 Recent Developments, 2017-2020
10.6 ABBVIE
10.6.1 Company Overview
10.6.2 Company Snapshot
10.6.3 Service Portfolio
10.6.4 Financial Analysis
10.6.4.1 Net Revenue, 2016-2020
10.6.4.2 Segmental Revenue Shares, 2020
10.6.4.3 Regional Revenue Shares, 2020
10.6.5 Recent Developments, 2020
10.7 SIEGFRIED HOLDING AG
10.7.1 Company Overview
10.7.2 Company Snapshot
10.7.3 Service Portfolio
10.7.4 Financial Analysis
10.7.4.1 Net Revenue, 2016-2020
10.7.5 Recent Developments, 2019
10.8 EVONIK INDUSTRIES
10.8.1 Company Overview
10.8.2 Company Snapshot
10.8.3 Service Portfolio
10.8.4 Financial Analysis
10.8.4.1 Net Revenue, 2016-2020
10.8.4.2 Segmental Revenue Shares, 2020
10.8.4.3 Regional Revenue Shares, 2019
10.8.5 Recent Developments, 2020
10.9 BOEHRINGER INGELHEIM
10.9.1 Company Overview
10.9.2 Company Snapshot
10.9.3 Service Portfolio
10.9.4 Financial Analysis
10.9.4.1 Net Revenue, 2016-2020
10.9.4.2 Segmental Revenue Shares, 2020
10.9.4.3 Regional Revenue Shares, 2020
10.9.5 Recent Developments, 2017-2019
10.10 PIRAMAL PHARMA SOLUTIONS
10.10.1 Company Overview
10.10.2 Company Snapshot
10.10.3 Service Portfolio
10.10.4 Financial Analysis
10.10.4.1 Net Revenue, 2017-2021
10.10.4.2 Segmental Revenue Shares, 2021
10.10.4.3 Regional Revenue Shares, 2021
10.10.5 Recent Developments, 2020
10.11 SAMSUNG BIOLOGICS
10.11.1 Company Overview
10.11.2 Company Snapshot
10.11.3 Service Portfolio
10.11.4 Financial Analysis
10.11.4.1 Segmental Revenue Shares, 2020
10.11.4.2 Regional Revenue Shares, 2020
10.11.5 Recent Developments, 2017-2020
10.12 WUXI APPTEC (WUXI STA)
10.12.1 Company Overview
10.12.2 Company Snapshot
10.12.3 Service Portfolio
10.12.4 Recent Developments, 2018-2020
10.13 FUJIFILM HEALTHCARE
10.13.1 Company Overview
10.13.2 Company Snapshot
10.13.3 Service Portfolio
10.13.4 Financial Analysis
10.13.4.1 Net Revenue, 2016-2019
10.13.4.2 Segmental Revenue Shares, 2019
10.13.4.3 Regional Revenue Shares, 2019
10.13.5 Recent Developments, 2017-2018
10.14 ICON PLC
10.14.1 Company Overview
10.14.2 Company Snapshot
10.14.3 Service Portfolio
10.15 ABNOVA CORPORATION
10.15.1 Company Overview
10.15.2 Company Snapshot
10.15.3 Service Portfolio
10.16 VETTER PHARMA INTERNATIONAL
10.16.1 Company Overview
10.16.2 Company Snapshot
10.16.3 Service Portfolio

11 Conclusion and Recommendations
11.1 Concluding Remarks from Visiongain
11.2 Recommendations for Market Players
11.3 Leading and Fastest Growing Region

List of Tables
Table 1 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 2 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 3 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 4 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Global Pharmaceutical Contract Manufacturing Market Forecast by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 6 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 7 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 8 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 9 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 10 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 11 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical API Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 12 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 13 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 14 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 15 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 16 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical FDF Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 17 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 18 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 19 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 20 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 21 Global Pharmaceutical Contract Manufacturing Market Forecast For Parenteral/injectable manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 22 Global Pharmaceutical Contract Manufacturing Market Forecast For Tablet manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 23 Global Pharmaceutical Contract Manufacturing Market Forecast For Capsule manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 24 Global Pharmaceutical Contract Manufacturing Market Forecast For Oral liquid manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 25 Global Pharmaceutical Contract Manufacturing Market Forecast For Semi-solid manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 26 Global Pharmaceutical Contract Manufacturing Market Forecast For Other Formulation manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 27 Global Pharmaceutical Contract Manufacturing Market Forecast For Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 28 Global Pharmaceutical Contract Manufacturing Market Forecast For Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 29 Global Pharmaceutical Contract Manufacturing Market Forecast for Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 30 Global Pharmaceutical Contract Manufacturing Market Forecast for Drug
Figure 44. Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 31 Global Pharmaceutical Contract Manufacturing Market Forecast for Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 32 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 33 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 34 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 35 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 36 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 37 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 38 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 39 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 40 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 41 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 42 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics FDF Manufacture Service by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 43 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%) : V-Shaped Recovery
Table 44 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 45 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 46 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 47 Global Pharmaceutical Contract Manufacturing Market Forecast by End User, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 48 Global Pharmaceutical Contract Manufacturing Market Forecast For Big Pharmaceutical Companies by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 49 Global Pharmaceutical Contract Manufacturing Market Forecast for Big Pharmaceutical Companies (PCR), 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 50 Global Pharmaceutical Contract Manufacturing Market Forecast for Big Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 51 Global Pharmaceutical Contract Manufacturing Market Forecast for Big Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 52 Global Pharmaceutical Contract Manufacturing Market Forecast for Big Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 53 Global Pharmaceutical Contract Manufacturing Market Forecast For Small & Medium-Sized Pharmaceutical Companies by Region, 2022-2032 (US$ billion, AGR%, CAGR%)
Table 54 Global Pharmaceutical Contract Manufacturing Market Forecast for Small & Medium-Sized Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 55 Global Pharmaceutical Contract Manufacturing Market Forecast for Small & Medium-Sized Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 56 Global Pharmaceutical Contract Manufacturing Market Forecast for Small & Medium-Sized Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 57 Global Pharmaceutical Contract Manufacturing Market Forecast for Small & Medium-Sized Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 58 Global Pharmaceutical Contract Manufacturing Market Forecast For Generic Pharmaceutical Companies by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 59 Global Pharmaceutical Contract Manufacturing Market Forecast For Generic Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 60 Global Pharmaceutical Contract Manufacturing Market Forecast For Generic Pharmaceutical Companies (ISH), 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 61 Global Pharmaceutical Contract Manufacturing Market Forecast for Generic Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 62 Global Pharmaceutical Contract Manufacturing Market Forecast for Generic Pharmaceutical Companies, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 63 Global Pharmaceutical Contract Manufacturing Market Forecast For Other End Users by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 64 Global Pharmaceutical Contract Manufacturing Market Forecast For Other End Users, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 65 Global Pharmaceutical Contract Manufacturing Market Forecast For Other End Users, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 66 Global Pharmaceutical Contract Manufacturing Market Forecast for Other End Users, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 67 Global Pharmaceutical Contract Manufacturing Market Forecast for Other End Users, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 68 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR
Table 69 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 70 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 71 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 72 North America Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 73 North America Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 74 North America Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 75 North America Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 76 North America Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 77 North America Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 78 US Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 79 US Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 80 US Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 81 US Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 82 US Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 83 US Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 84 US Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 85 Canada Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 86 Canada Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 87 Canada Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 88 Canada Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 89 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 90 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 92 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 93 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 94 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR
Table 95 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 96 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 97 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 98 Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 99 Europe Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 100 Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 101 Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 102 Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 103 Europe Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 104 Germany Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 105 Germany Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 106 Germany Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 107 Germany Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 108 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 109 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 110 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 111 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 112 UK Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 113 UK Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 114 UK Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 115 UK Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 116 UK Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 117 UK Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 118 UK Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 119 UK Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 120 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 121 Switzerland Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 122 Switzerland Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 123 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 124 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 125 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 126 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 127 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 128 France Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 129 France Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 130 France Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 131 France Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 132 France Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 133 France Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 134 France Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 135 France Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 136 Italy Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 137 Italy Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 138 Italy Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 139 Italy Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 140 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 141 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 142 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 143 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 144 Spain Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 145 Spain Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 146 Spain Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 147 Spain Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 148 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 149 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 150 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 151 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 152 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 153 Rest of Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 154 Rest of Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 155 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 156 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 157 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 158 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 159 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 160 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR
Table 161 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 162 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 163 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 164 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 165 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 166 Asia-Pacific Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 167 Asia-Pacific Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 168 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 169 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 170 Japan Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 171 Japan Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 172 Japan Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 173 Japan Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 174 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 175 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 176 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 177 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 178 China Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 179 China Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 180 China Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 181 China Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 182 China Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 183 China Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 184 China Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 185 China Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 186 India Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 187 India Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 188 India Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 189 India Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 190 India Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 191 India Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 192 India Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 193 India Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 194 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 195 South Korea Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 196 South Korea Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 197 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 198 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 199 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 200 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 201 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 202 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 203 Rest of APAC Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 204 Rest of APAC Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 205 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 206 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 207 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 208 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 209 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 209 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR
Table 210 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 211 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 212 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 213 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 214 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 215 LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 216 LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 217 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 218 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 219 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 220 Brazil Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 221 Brazil Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 222 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 223 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 224 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 225 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 226 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 227 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 229 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 230 Mexico Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 231 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 232 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 233 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 234 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 235 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 236 Saudi Arabia Pharmaceutical Contract Manufacturing Market Value by Service, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 237 Saudi Arabia Pharmaceutical Contract Manufacturing Market Value by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 238 Saudi Arabia Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 239 Saudi Arabia Pharmaceutical Contract Manufacturing Market Share Forecast by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 240 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 241 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 242 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 243 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
Table 244 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 245 Rest of LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 246 Rest of LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 247 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 248 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “V” Shaped Recovery
Table 249 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “U” Shaped Recovery
Table 250 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “L” Shaped Recovery
Table 251 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): “W” Shaped Recovery
?

List of Figures
Figure 1 Global Pharmaceutical Contract Manufacturing Market Segmentation
Figure 2 Global Pharmaceutical Contract Manufacturing Market: Market Trends
Figure 3 Global Pharmaceutical Contract manufacturing Market: SWOT Analysis
Figure 4 Pharmaceutical Contract Manufacturing Market Porter’s Five Forces.
Figure 5 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: V-Shaped Recovery
Figure 6 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: U-Shaped Recovery
Figure 7 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: L-Shaped Recovery
Figure 8 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market (USD Billion), 2022-2032: W-Shaped Recovery
Figure 9 Global Pharmaceutical Contract Manufacturing Market Forecast by Services, Forecast by Region, 2022-2032 (US$ billion, AGR %)
Figure 9. Global Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2021, 2027, 2032 (%)
Figure 10. Global Pharmaceutical Contract Manufacturing Market Share For Pharmaceutical Manufacturing Services, Forecast by Region, 2022-2032 (US$ billion, AGR %)
Figure 11. Global Pharmaceutical Contract Manufacturing Market Share for Pharmaceutical Manufacturing Services, Forecast by Region, 2021, 2027, 2032 (%)
Figure 12. Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services, 2022-2032 (US$ bill

この商品のレポートナンバー

0000031858

TOP